Kerndatensatz Senologie
0.9.0 - ci-build
Kerndatensatz Senologie - Local Development build (v0.9.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Draft as of 2026-05-04 |
{
"resourceType" : "CodeSystem",
"id" : "cs-senologie-genexpressionstest",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem cs-senologie-genexpressionstest</b></p><a name=\"cs-senologie-genexpressionstest\"> </a><a name=\"hccs-senologie-genexpressionstest\"> </a><p>This case-sensitive code system <code>https://www.senologie.org/fhir/CodeSystem/cs-senologie-genexpressionstest</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">oncotype-dx<a name=\"cs-senologie-genexpressionstest-oncotype-dx\"> </a></td><td>Oncotype DX</td><td>21-Gen Recurrence Score Assay (Exact Sciences). Score 0–100.</td></tr><tr><td style=\"white-space:nowrap\">mammaprint<a name=\"cs-senologie-genexpressionstest-mammaprint\"> </a></td><td>MammaPrint</td><td>70-Gen Signatur (Agendia). Index -1.0 bis +1.0.</td></tr><tr><td style=\"white-space:nowrap\">prosigna<a name=\"cs-senologie-genexpressionstest-prosigna\"> </a></td><td>Prosigna (PAM50)</td><td>50-Gen ROR Score Assay (Veracyte). Score 0–100.</td></tr><tr><td style=\"white-space:nowrap\">endopredict<a name=\"cs-senologie-genexpressionstest-endopredict\"> </a></td><td>EndoPredict</td><td>12-Gen EPclin Score (Myriad Genetics). Kontinuierlicher Score.</td></tr></table></div>"
},
"url" : "https://www.senologie.org/fhir/CodeSystem/cs-senologie-genexpressionstest",
"version" : "0.9.0",
"name" : "CS_Senologie_Genexpressionstest",
"title" : "CS Senologie Genexpressionstest",
"status" : "draft",
"date" : "2026-05-04T16:55:55+00:00",
"publisher" : "Berlin Institute of Health at Charité (BIH)",
"contact" : [
{
"name" : "Berlin Institute of Health at Charité (BIH)",
"telecom" : [
{
"system" : "url",
"value" : "https://www.bihealth.org"
}
]
}
],
"description" : "Genexpressionstests zur Abschätzung des Rezidivrisikos bei Mammakarzinom",
"caseSensitive" : true,
"content" : "complete",
"count" : 4,
"concept" : [
{
"code" : "oncotype-dx",
"display" : "Oncotype DX",
"definition" : "21-Gen Recurrence Score Assay (Exact Sciences). Score 0–100."
},
{
"code" : "mammaprint",
"display" : "MammaPrint",
"definition" : "70-Gen Signatur (Agendia). Index -1.0 bis +1.0."
},
{
"code" : "prosigna",
"display" : "Prosigna (PAM50)",
"definition" : "50-Gen ROR Score Assay (Veracyte). Score 0–100."
},
{
"code" : "endopredict",
"display" : "EndoPredict",
"definition" : "12-Gen EPclin Score (Myriad Genetics). Kontinuierlicher Score."
}
]
}